ETR:FME

Fresenius Medical Care AG & Co. KGaA Stock Forecast, Price & News

€63.30
+0.16 (+0.25 %)
(As of 04/15/2021 12:00 AM ET)
Add
Compare
Today's Range
€62.76
Now: €63.30
€63.40
50-Day Range
€57.20
MA: €61.19
€63.84
52-Week Range
€55.18
Now: €63.30
€79.96
Volume599,879 shs
Average Volume704,197 shs
Market Capitalization$18.54 billion
P/E Ratio15.98
Dividend Yield2.12%
BetaN/A
Fresenius Medical Care AG & Co. KGaA provides dialysis care and related dialysis care services in Germany, North America, and internationally. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. The company also develops, manufactures, and distributes dialysis products, including polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, and systems for water treatment; and non-dialysis products, such as acute cardiopulmonary and apheresis products. In addition, it develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, vascular care ambulatory surgery center, and physician nephrology and cardiology services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents. As of December 31, 2020, it operated 4,092 outpatient dialysis clinics in approximately 150 countries. Fresenius Medical Care AG & Co. KGaA was incorporated in 1996 and is headquartered in Bad Homburg, Germany.
Fresenius Medical Care AG & Co. KGaA logo

Industry, Sector and Symbol

Industry Medical Care
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+49-6172-6090
Employees125,364
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$17.86 billion
Cash Flow€4.32 per share
Book Value€38.29 per share

Profitability

Miscellaneous

Market Cap$18.54 billion
Next Earnings Date5/6/2021 (Estimated)
OptionableNot Optionable

Headlines

News for Fresenius Medical Care AG & Co. KGaA (FMC) St.
December 18, 2020 |  markets.businessinsider.com
Is Fresenius Medical Care (FMS) a Good Stock to Pick Now?
December 7, 2020 |  finance.yahoo.com
New Strong Buy Stocks For August 18th
August 18, 2020 |  nasdaq.com
See More Headlines

MarketRank

Overall MarketRank

1.82 out of 5 stars

Analyst Opinion: 3.2Community Rank: 3.0Dividend Strength: 1.7Insider Behavior: 0.0Valuation: 1.3 5 -4 -3 -2 -1 -
€63.30
+0.16 (+0.25 %)
(As of 04/15/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive FME News and Ratings via Email

Sign-up to receive the latest news and ratings for FME and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Fresenius Medical Care AG & Co. KGaA (ETR:FME) Frequently Asked Questions

Is Fresenius Medical Care AG & Co. KGaA a buy right now?

14 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Fresenius Medical Care AG & Co. KGaA in the last year. There are currently 1 sell rating, 7 hold ratings and 6 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" Fresenius Medical Care AG & Co. KGaA stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in FME, but not buy additional shares or sell existing shares.
View analyst ratings for Fresenius Medical Care AG & Co. KGaA
or view top-rated stocks.

What stocks does MarketBeat like better than Fresenius Medical Care AG & Co. KGaA?

Wall Street analysts have given Fresenius Medical Care AG & Co. KGaA a "Hold" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Fresenius Medical Care AG & Co. KGaA wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Fresenius Medical Care AG & Co. KGaA's next earnings date?

Fresenius Medical Care AG & Co. KGaA is scheduled to release its next quarterly earnings announcement on Thursday, May 6th 2021.
View our earnings forecast for Fresenius Medical Care AG & Co. KGaA
.

How has Fresenius Medical Care AG & Co. KGaA's stock price been impacted by COVID-19?

Fresenius Medical Care AG & Co. KGaA's stock was trading at €63.68 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, FME stock has decreased by 0.6% and is now trading at €63.30.
View which stocks have been most impacted by COVID-19
.

Is Fresenius Medical Care AG & Co. KGaA a good dividend stock?

Fresenius Medical Care AG & Co. KGaA pays an annual dividend of €1.34 per share and currently has a dividend yield of 2.12%. The dividend payout ratio of Fresenius Medical Care AG & Co. KGaA is 33.84%. This payout ratio is at a healthy, sustainable level, below 75%.
View Fresenius Medical Care AG & Co. KGaA's dividend history.

What price target have analysts set for FME?

14 Wall Street analysts have issued 12-month price targets for Fresenius Medical Care AG & Co. KGaA's shares. Their forecasts range from €52.40 to €89.00. On average, they anticipate Fresenius Medical Care AG & Co. KGaA's stock price to reach €69.92 in the next year. This suggests a possible upside of 10.5% from the stock's current price.
View analysts' price targets for Fresenius Medical Care AG & Co. KGaA
or view top-rated stocks among Wall Street analysts.

Who are Fresenius Medical Care AG & Co. KGaA's key executives?

Fresenius Medical Care AG & Co. KGaA's management team includes the following people:
  • Mr. Robert Maurice Powell Jr., Chairman of the Management Board & CEO of Fresenius Medical Care Management AG (Age 66, Pay $4.05M)
  • Ms. Helen Giza, CFO & Member of Management Board of Fresenius Medical Care Management AG (Age 53, Pay $2.07M)
  • Mr. Kent Wanzek, CEO of Global Mfg, Quality & Supply and Member of Management Board - Fresenius Medical Care Mgmt AG (Age 62, Pay $2.31M)
  • Dr. Franklin W. Maddux F.A.C.P., M.D., Global Chief Medical Officer & Member of Management Board of Fresenius Medical Care Management AG (Age 64, Pay $1.85M)
  • Dr. Olaf Schermeier, CEO of Global R&D and Member of the Management Board of Fresenius Medical Care Management AG (Age 49, Pay $2.13M)
  • Mr. Harry de Wit, CEO of Asia-Pacific Segment & Member of Management Board of Fresenius Medical Care Management AG (Age 59, Pay $2.45M)
  • Mr. William Valle, CEO of North America Segment & Member of Management Board of Fresenius Medical Care Management AG (Age 61, Pay $7.28M)
  • Dr. Katarzyna Mazur-Hofsab Ph.D., CEO for EMEA Segment & Member of Management Board of Fresenius Medical Care Management AG (Age 58, Pay $1.9M)
  • Ms. Rachel Clare Empey, Member of Supervisory Board of Fresenius Medical Care Management AG (Age 45, Pay $77k)
  • Dr. Dominik Heger, Exec. VP and Head of Investor Relations, Strategic Devel. & Communications

Who are some of Fresenius Medical Care AG & Co. KGaA's key competitors?

What other stocks do shareholders of Fresenius Medical Care AG & Co. KGaA own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Fresenius Medical Care AG & Co. KGaA investors own include Petra Diamonds (PDL), Nokia Oyj (NOKIA), Fresenius Medical Care AG & Co. KGaA (FMS), RWE Aktiengesellschaft (RWE), Deutsche Lufthansa (LHA), Rio Tinto Group (RIO), Covestro (1COV), Carillion (CLLN), Nokia (NOK) and Oxford Biomedica (OXB).

What is Fresenius Medical Care AG & Co. KGaA's stock symbol?

Fresenius Medical Care AG & Co. KGaA trades on the ETR under the ticker symbol "FME."

What is Fresenius Medical Care AG & Co. KGaA's stock price today?

One share of FME stock can currently be purchased for approximately €63.30.

How much money does Fresenius Medical Care AG & Co. KGaA make?

Fresenius Medical Care AG & Co. KGaA has a market capitalization of $18.54 billion and generates $17.86 billion in revenue each year.

How many employees does Fresenius Medical Care AG & Co. KGaA have?

Fresenius Medical Care AG & Co. KGaA employs 125,364 workers across the globe.

What is Fresenius Medical Care AG & Co. KGaA's official website?

The official website for Fresenius Medical Care AG & Co. KGaA is www.freseniusmedicalcare.com.

Where are Fresenius Medical Care AG & Co. KGaA's headquarters?

Fresenius Medical Care AG & Co. KGaA is headquartered at Else-Kroener-Strasse 1, BAD HOMBURG, 61352, Germany.

How can I contact Fresenius Medical Care AG & Co. KGaA?

Fresenius Medical Care AG & Co. KGaA's mailing address is Else-Kroener-Strasse 1, BAD HOMBURG, 61352, Germany. The company can be reached via phone at +49-6172-6090.


This page was last updated on 4/16/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.